Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.3 on the page. This reflects a metadata/version update rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-06-29T20:04:32.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Enrollment status was updated to indicate no participant recruitment is currently ongoing. New user-focused sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and a revision note (Revision: v3.6.0) was included.
    Difference
    0.3%
    Check dated 2026-06-15T12:46:20.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a behind-the-scenes update to the site; no study information or results are affected.
    Difference
    0.0%
    Check dated 2026-06-08T05:38:19.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The revision history now lists a new Revision: v3.5.4, replacing the previous Revision: v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-18T03:28:18.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from version v3.5.2 to v3.5.3, indicating a minor platform/version update rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-04-26T15:16:20.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T12:46:33.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.